MSB 3.76% $1.03 mesoblast limited

Ann: FDA Grants Orphan Drug Designation for Revascor, page-60

  1. 3,865 Posts.
    lightbulb Created with Sketch. 281
    I am not as vocal as @Pledge regarding the incompetence of Si, however I do agree with him in the most part, and also your sentiments.

    20 years wasted beating your own chest doesn't get an approval if you think you are above the guidance given by the FDA.

    That said now, when we get approval, it will be 20 years of research to report which will show that the product isn't an overnight thought.

    Yes I am down on investment but not on hope.

    There are others that are years behind MSB who are down the toilet in SP price as well.

    No approval game over, with approval game on with rockets, if Si follows the Ikea instructions.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.03
Change
-0.040(3.76%)
Mkt cap ! $1.170B
Open High Low Value Volume
$1.07 $1.07 $1.01 $13.19M 12.81M

Buyers (Bids)

No. Vol. Price($)
3 61090 $1.02
 

Sellers (Offers)

Price($) Vol. No.
$1.03 239558 5
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.